Business & Economy | Indiablooms - First Portal on Digital News Management

November 05, 2024 11:04 (IST)

Make this your homepage

All Business & Economy

Pakistan's Lahore has become world's most polluted city with an AQI of 1900 on Sunday | Indian Army 'successfully completes' patrolling to a key point in Ladakh's Depsang region | US presidential election: Donald Trump ahead of Kamala Harris in swing states, poll survey predicts | 'I strongly condemn Hindu temple attack, intimidation of our diplomats': PM Modi amid Canada row | 'I strongly condemn Hindu temple attack, intimidation of our diplomats': PM Modi amid Canada row

Sun Pharma Q4FY24 PAT grows 34% to Rs 2,655 cr; Rs 5 per share dividend declared

Mumbai: Leading pharmaceutical company Sun Pharmaceutical Industries Ltd announced a consolidated net profit of Rs 2,654.5 crore for the March quarter, a 34 percent increase from the same period last year, media reported.

Sun Pharma to acquire 16.33 pc stake in US-based Surgimatix

Sun Pharma on Tuesday said that it has decided to acquire a 16.33% stake in the US-based Surgimatix for US$ 3.05 million.

Sun Pharma FY24 Sept qtr net profit grows 5% to Rs 2,376 cr

Mumbai: Leading pharma company Sun Pharmaceutical Industries Ltd Wednesday reported a 5% increase in its net profit for the July-September quarter, reaching Rs 2,375.5 crore compared to Rs 2,262.2 crore in the corresponding period last year.

Sun Pharma drops 3.11 per cent to Rs 860.45

Mumbai: Sun Pharma on Tuesday slid 3.11 per cent to Rs 860.45 a major loser in 30 scrips of BSE.

Sun Pharma moves up 3.99 pc to touch Rs 855.55

Mumbai/UNI/IBNS: Sun Pharma on Tuesday rose 3.99 per cent to Rs 855.55, a major gainer in 30 scrips of the BSE.

Sun Pharma moves down by 3.06 pc to Rs 789.70

Mumbai/UNI: Sun Pharma on Wednesday tumbled down by 3.06 pc to Rs 789.70 a major loser in 30 scrips of BSE.

Sun Pharma moves up by 5.51 pc to Rs 539.75

Mumbai/UNI: Sun Pharma on Tuesday surged by 5.51 pc to Rs 539.75 a major gainer in 30 scrips of BSE.

Sun Pharma losses 7.34 pct

Mumbai/UNI: Sun Pharma on Monday tumbled down by 7.34 per cent to Rs 515 a major loser in 30 scrips of BSE while ONGC by 1.74 per cent was the top gainer.

Sun Pharma Q1 consolidated loss at Rs 1655.60 cr

Mumbai, Jul 31 (UNI) Pharma major, Sun Pharma reported a net loss of Rs 1655.60 crores for the quarter ended June 30, 2020 as against net profit of Rs.1387.48 crores for the quarter ended June 30.